Position in APGE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,128,205
+$757,857 QoQ
Shares Held
8,500
+93.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#180
of 285 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STRS OHIO holds $177,004,891 across 155 Biotechnology names. APGE ranks #27 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66,679 | $33,121,459 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,557 | $17,806,431 | |
| 3 | MRNA |
Moderna, Inc.
|
209,874 | $14,697,476 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
299,838 | $10,611,266 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
54,428 | $10,193,275 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,364 | $10,043,564 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
38,166 | $3,026,182 | |
| 8 | EXEL |
Exelixis, Inc.
|
52,093 | $2,834,380 |
All Filings in APGE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,128,205 | 8,500 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $370,348 | 4,400 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $249,084 | 3,300 | Shares | Sole | 2026-02-02 | |
| 2024-12-31 | $249,150 | 5,500 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $358,314 | 6,100 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $240,035 | 6,100 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $259,155 | 3,900 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $114,554 | 4,100 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $87,330 | 4,100 | Shares | Sole | 2023-10-26 | |
| No filing history on record for this holder in this stock. | ||||||